Andrew Hindman
2016
In 2016, Andrew Hindman earned a total compensation of $1.8M as Chief Business Development Officer at Acorda Therapeutics, a 51% increase compared to previous year.
Compensation breakdown
| Bonus | $95,000 |
|---|---|
| Non-Equity Incentive Plan | $196,176 |
| Option Awards | $688,628 |
| Salary | $408,700 |
| Stock Awards | $408,027 |
| Other | $7,950 |
| Total | $1,804,481 |
Hindman received $688.6K in option awards, accounting for 38% of the total pay in 2016.
Hindman also received $95K in bonus, $196.2K in non-equity incentive plan, $408.7K in salary, $408K in stock awards and $8K in other compensation.
Rankings
In 2016, Andrew Hindman's compensation ranked 5,370th out of 14,075 executives tracked by ExecPay. In other words, Hindman earned more than 61.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,370 out of 14,075 | 62nd |
Division Manufacturing | 1,926 out of 5,489 | 65th |
Major group Chemicals And Allied Products | 612 out of 1,895 | 68th |
Industry group Drugs | 457 out of 1,538 | 70th |
Industry Biological Products, Except Diagnostic Substances | 79 out of 279 | 72nd |
Source: SEC filing on April 21, 2017.
Hindman's colleagues
We found five more compensation records of executives who worked with Andrew Hindman at Acorda Therapeutics in 2016.
2016
Burkhard Blank
Acorda Therapeutics
Chief Medical Officer
2016
Ron Cohen
Acorda Therapeutics
Chief Executive Officer
2016
Jane Wasman
Acorda Therapeutics
General Counsel
2016
Michael Rogers
Acorda Therapeutics
Chief Financial Officer
2016
David Lawrence
Acorda Therapeutics